BRISTACYCLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bristacycline, and what generic alternatives are available?
Bristacycline is a drug marketed by Bristol and is included in two NDAs.
The generic ingredient in BRISTACYCLINE is tetracycline hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bristacycline
A generic version of BRISTACYCLINE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BRISTACYCLINE?
- What are the global sales for BRISTACYCLINE?
- What is Average Wholesale Price for BRISTACYCLINE?
Summary for BRISTACYCLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Patent Applications: | 4,069 |
| DailyMed Link: | BRISTACYCLINE at DailyMed |
US Patents and Regulatory Information for BRISTACYCLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061658-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061888-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061888-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol | BRISTACYCLINE | tetracycline hydrochloride | CAPSULE;ORAL | 061658-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
